Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11049364 | 0.88 | TSHR (0.36) | TSHR | |
| SCHEMBL12418599 | 0.88 | TSHR (0.36) | TSHR | |
| SCHEMBL9808403 | 0.88 | TSHR (0.36) | TSHR | |
| SCHEMBL4666436 | 0.82 | TSHR (0.39) | TSHR | |
| SCHEMBL28713347 | 0.82 | ALDH1A1 (0.67) | TSHRALDH1A1THRB | |
| SCHEMBL10756606 | 0.79 | TSHR (0.33) | TSHR | |
| SCHEMBL993354 | 0.79 | — | — | |
| SCHEMBL8463868 | 0.79 | — | — | |
| SCHEMBL3209857 | 0.79 | — | — | |
| SCHEMBL31266934 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119537-A | PVDF-based composite membrane and preparation method thereof | 重庆文理学院 | 2024-12-13 | — | — | CN | claimed |
| CN-117285437-B | Bexarotene derivative, preparation method and application thereof, and anti-tumor drug | 沈阳药科大学 | 2024-09-17 | — | — | CN | claimed |
| CN-117285437-A | Bexarotene derivative, preparation method and application thereof, and anti-tumor drug | 沈阳药科大学 | 2023-12-26 | — | — | CN | claimed |
| CN-112479918-B | Synthesis method of retinoic acid derivative Am580 | 成都大学 | 2023-07-14 | — | — | CN | claimed |
| CN-114075125-A | Long-chain alkyl fluorine-containing sulfonate ionic membrane compound for blocking water permeation of lithium-air battery | 上海漫关越水处理有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-112479918-A | Synthetic method of retinoid derivative Am580 | 成都大学 | 2021-03-12 | — | — | CN | claimed |
| EP-2004611-A1 | PROCESS FOR PREPARING RETINOID COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2008-12-24 | — | — | EP | claimed |
| WO-2007113122-A1 | PROCESS FOR PREPARING RETINOID COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-10-11 | — | — | WO | claimed |
| US-20070232810-A1 | Process for preparing retinoid compounds | ROCHE PALO ALTO LLC | 2007-10-04 | — | — | US | claimed |
| EP-0436775-A2 | New Polymers and copolymers and method and initiation system for their preparation | Ceskoslovenska akademie ved (CS) | 1991-07-17 | — | — | EP | claimed |
| US-3980724-A | Dihalogenation of doubly branched alkanes | SUN VENTURES, INC. (US) | 1976-09-14 | — | — | US | claimed |
| US-12617880-B2 | Compounds for use in catalyst compositions for the production of polyolefins | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2026-05-05 | — | — | US | disclosed |
| US-20260008740-A1 | BEXAROTENE DERIVATIVES AND THEIR USE IN TREATING CANCER | DJ Therapeutics LLC (US) | 2026-01-08 | — | — | US | disclosed |
| US-12338214-B2 | Bexarotene derivatives and their use in treating cancer | DJ Therapeutics LLC (US) | 2025-06-24 | — | — | US | disclosed |
| EP-4543430-A1 | SYNTHESIS OF TETRAHYDRONAPHTHALENOLS AND USES THEREOF | IO Therapeutics, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-4454341-A | ANTITUMOR, SKIN DISORDERS | SRI INTERNATIONAL (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0098591-A1 | Heterocyclic compounds and rodenticides containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-01-18 | — | — | EP | disclosed |
| EP-0098546-A1 | Novel aromatic musks | FRITZSCHE DODGE & OLCOTT INC. (US) | 1984-01-18 | — | — | EP | disclosed |
| US-4146576-A | MANUFACTURE OF CARBON FIBRES | COAL INDUSTRY (PATENTS) LIMITED (GB) | 1979-03-27 | — | — | US | disclosed |
| US-3980724-A | Dihalogenation of doubly branched alkanes | SUN VENTURES, INC. (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617880-B2 | Compounds for use in catalyst compositions for the production of polyolefins | PRMT5, CBR3, MET | TSHR 176/4885ALDH1A1 1762/4885THRB 597/4885 |
| US-12338214-B2 | Bexarotene derivatives and their use in treating cancer | C3AR1, CXCR3, CCR7 | TSHR 594/4885ALDH1A1 1553/4885THRB 2530/4885 |
| US-20260008740-A1 | BEXAROTENE DERIVATIVES AND THEIR USE IN TREATING CANCER | CXCR3, CCR6, CCR9 | TSHR 369/4885ALDH1A1 2561/4885THRB 1972/4885 |
| US-20070232810-A1 | Process for preparing retinoid compounds | RARB, RARG, RARA | TSHR 197/4885ALDH1A1 138/4885THRB 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.